The list of IT vendors and service providers that have yet to strike a deal with AstraZeneca ($AZN) in 2015 keeps getting shorter...

This story appeared in the San Diego Business Journal. Making a drug used to fall to Big Pharma, costing a billion dollars and requiring resources...

I’ve been thinking a lot lately about how to optimize for ligand affinity. Of course, this is a central theme of all drug discovery projects. At...

Anyone who has taken a general laboratory class knows that the lab manual has multiple protocols that one follows in order to complete each week’s...

Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below it, and a solid...

Innovation is suddenly the word on everybody’s lips. Pfizer launched “Centers for Therapeutic Innovation”, Johnson and Johnson followed with their...

Sometimes, in tragic circumstances, a lesson can be learned and applied in unexpected ways. That appears to be the case with a rare disease that...

We have recently discussed here how crowdfunding – donations from the general public in support of a cause, idea, or invention – has caught the...

It’s been two years in the making, but a digital portal now connects 10 Kansas City-area research organizations with one another and with the...

As we previously discussed, CRISPR-mania is sweeping the globe. (Okay, it might not be as big as Beatlemania, but more than a few life science...